Weighted-Average Shares Outstanding (Diluted): The number of shares held by shareholders including insiders but not including a company's treasury shares assuming conversion of all convertible debt, securities, warrants and options, sourced from the company 10-K or 10-Q SEC reports.
ZIVO Bioscience, Inc. (ZIVO) had Weighted-Average Shares Outstanding (Diluted) of 3.82M for the most recently reported fiscal quarter, ending 2025-09-30.
| Income Statement Financials | |
$0.07M |
|
$-1.03M |
|
$0.04M |
|
$0.02M |
|
$1.08M |
|
$-1.02M |
|
$-0.01M |
|
$-1.03M |
|
$-1.03M |
|
$-1.03M |
|
$-1.03M |
|
$-1.03M |
|
$-1.03M |
|
$-1.02M |
|
$-1.02M |
|
3.82M |
|
|
Weighted-Average Shares Outstanding (Diluted) |
3.82M |
$-0.27 |
|
$-0.27 |
|
| Balance Sheet Financials | |
$0.28M |
|
-- |
|
$0.28M |
|
$0.56M |
|
$3.61M |
|
$0.01M |
|
$0.23M |
|
$3.85M |
|
$-3.29M |
|
$-3.29M |
|
$-3.29M |
|
3.83M |
|
| Cash Flow Statement Financials | |
$-2.17M |
|
-- |
|
$0.69M |
|
$1.54M |
|
$0.06M |
|
$-1.49M |
|
$0.96M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.08 |
|
-- |
|
-- |
|
-0.00 |
|
-0.05 |
|
32.44% |
|
-1551.76% |
|
-1551.76% |
|
-- |
|
-1574.18% |
|
-1574.18% |
|
$-2.17M |
|
-- |
|
-- |
|
-- |
|
0.12 |
|
-- |
|
-- |
|
-- |
|
31.43% |
|
31.43% |
|
-184.66% |
|
31.54% |
|
$-0.86 |
|
$-0.57 |
|
$-0.57 |
|